Definitive Contract 75N91021C00040
Award Date
9/22/21
Potential Completion Date
8/31/22
Potential Value
$455K
Federal Agency
National Cancer Institute
Awardee
Sentimetrix, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
8
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This $2,049,554 firm fixed price definitive contract was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Sentimetrix, Inc., a for-profit small business. The contract supports the SBIR Phase II effort for "POSTURE ANALYSIS THROUGH MACHINE LEARNING (PATHML)," which was previously funded under a $454,907 SBIR Phase I contract in 2021. The PATHML effort aims to develop machine learning techniques to analyze human posture...
This is a $340,334.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian federal agency, to Genomic Expression Inc., a woman-owned small business. The contract is for the EO 14042 SBIR TOPIC 425 PHASE I: POSTURE ANALYSIS THROUGH MACHINE LEARNING (PATHML) research project, which is part of the Small Business Innovation Research (SBIR) program. The contract has a period of performance ending on February 27, 2024. As an SBIR Phase I award, this contract is focused on the...
This definitive contract was awarded by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, to Intelligent Automation, LLC. The $399,980 firm fixed price contract is for Phase I of the SBIR program's TOPIC 412, which seeks the development of a wearables-agnostic platform for continuous health monitoring and predictions to support cancer patients. The one-year period of performance will take place in Derwood,...
This $354,994.00 federal contract award was made by the National Cancer Institute (NCI) to Columbus Nanoworks, Inc., a small business biotechnology research company, for a Phase I Small Business Innovation Research (SBIR) project titled "POSTURE ANALYSIS THROUGH MACHINE LEARNING (PATHML)." The project is focused on developing a quantum-based diagnostic for microRNA in inflammatory breast cancer, which aligns with NCI's broader research objectives in cancer diagnostics and...
This is a $455,000 firm fixed price contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The contract was awarded to Mrimath LLC, a small disadvantaged, woman-owned limited liability company, for a Small Business Innovation Research (SBIR) Phase I project related to Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. The contract has a...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
<p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $1,416,758.40 Cost Plus Fixed Fee contract to Sensopath Technologies, Inc., a Woman Owned Small Business, for a Small Business Innovation Research (SBIR) Program Phase II action. The contract, which has a total small business set aside, was awarded on September 28, 2012 with an ultimate completion date of May 22, 2015. The contract delivers research and development services under the SBIR program.</p>
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to APDM, Inc., a for-profit manufacturer of digital health and wearable sensor technologies. The contract, valued at $1,457,589.00, is for the development of a wearable system to assess fall risk associated with cancer treatment. As an SBIR Phase II contract, this effort builds upon prior Phase I work. The contract has a...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a $224,759 Firm Fixed Price contract to Litmus Health, Inc., a small business, to develop an extensible and scalable platform for data integration from wearable sensors to generate novel analytics for cancer patients. This award is associated with the NIH/Centers for Disease Control and Prevention (CDC) Small Business Innovation Research (SBIR) Program Solicitation PHS...
This $390,181 firm fixed price contract was awarded by the National Institutes of Health National Cancer Institute to Smart Information Flow Technologies LLC for research activities aligned with TOPIC 425: CHARACTERIZING HUMAN ACTIVITIES FOR CANCER HEALTH AWARENESS under the Small Business Innovation Research Program Phase I solicitation. The prime contractor will conduct research and development at its Minneapolis, Minnesota location to deliver innovative solutions in cancer health awareness as...